An incorrect advisory alert saying Beyond Cancer's clinical trial approval was wrongly tagged to Beyond Air XAIR.O has been withdrawn.
Beyond Cancer is a unit of biopharma company Beyond Air, and the original alert from Beyond Cancer's press release was correctly coded.
For the correctly coded alert on Beyond Cancer's clinical trial approval, click nFWN3N415S
STORY_NUMBER: nFWN3N410N
STORY_DATE: 03/12/2024
STORY_TIME: 09:14:12 PM GMT
((bangalore.newsroom@thomsonreuters.com))